Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
LCTX
LCTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LCTX News
Lineage Cell Therapeutics Q4 2025 Earnings Call Insights
4d ago
seekingalpha
Lineage Cell Therapeutics Q4 Earnings Announcement Scheduled
5d ago
seekingalpha
Global Capital Shifts to Longevity Infrastructure Valued at $27 Trillion
Jan 29 2026
Newsfilter
Avant Technologies Drives 67.5% Market Share in Cell Therapy Manufacturing
Dec 16 2025
Newsfilter
Snowflake, Symbotic, and Other Major Stocks Decline in Thursday's Pre-Market Trading
Dec 04 2025
Benzinga
Lineage Cell Therapeutics, Inc. (LCTX) Shares Prepared Remarks at H.C. Wainwright's 27th Annual Global Investment Conference
Sep 13 2025
Newsfilter
Lineage Partners with William Demant Invest to Advance ReSonance™ (ANP1) for Hearing Loss Research
Aug 26 2025
Newsfilter
Lineage Cell Revenue Doubles in Q2
Aug 13 2025
NASDAQ.COM
Lineage signals expanded diversification strategy following OpRegen milestones and $42.3M cash position
Aug 12 2025
SeekingAlpha
Brookdale Senior Living (BKD) Reports Q2 Loss, Misses Revenue Estimates
Aug 06 2025
NASDAQ.COM
D. Boral Capital Maintains Buy on Lineage Cell Therapeutics, Maintains $2 Price Target
Aug 05 2025
Benzinga
Two Biotech Stocks Poised For Big Moves On Monday
Jun 23 2025
Benzinga
OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
Jun 23 2025
Newsfilter
Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC
May 14 2025
Newsfilter
Lineage Cell Therapeutics outlines manufacturing milestone and anticipates OpRegen 36-month data update while advancing OPC1 clinical plans
May 13 2025
SeekingAlpha
Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates
May 12 2025
NASDAQ.COM
Show More News
